vs
Side-by-side financial comparison of NEWMARKET CORP (NEU) and STEPAN CO (SCL). Click either name above to swap in a different company.
NEWMARKET CORP is the larger business by last-quarter revenue ($669.7M vs $604.5M, roughly 1.1× STEPAN CO). NEWMARKET CORP runs the higher net margin — 17.6% vs 3.3%, a 14.4% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -4.5%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs -2.9%).
NewMarket Corporation, is a publicly traded American company that primarily serves the petroleum additives industry. The company is based in Richmond, Virginia, and has operations in North America, Latin America, Europe, the Middle East and Asia Pacific. The company's predecessor, the Albemarle Paper Manufacturing Company, was founded in 1887.
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
NEU vs SCL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $669.7M | $604.5M |
| Net Profit | $118.1M | $19.7M |
| Gross Margin | 33.0% | 10.7% |
| Operating Margin | 21.4% | 4.7% |
| Net Margin | 17.6% | 3.3% |
| Revenue YoY | -4.5% | 1.9% |
| Net Profit YoY | -6.3% | — |
| EPS (diluted) | $12.62 | $0.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $669.7M | $604.5M | ||
| Q4 25 | $635.4M | $553.9M | ||
| Q3 25 | $690.3M | $590.3M | ||
| Q2 25 | $698.5M | $594.7M | ||
| Q1 25 | $700.9M | $593.3M | ||
| Q4 24 | $654.6M | $525.6M | ||
| Q3 24 | $724.9M | $546.8M | ||
| Q2 24 | $710.2M | $556.4M |
| Q1 26 | $118.1M | $19.7M | ||
| Q4 25 | $81.3M | $5.0M | ||
| Q3 25 | $100.3M | $10.8M | ||
| Q2 25 | $111.2M | $11.3M | ||
| Q1 25 | $125.9M | $19.7M | ||
| Q4 24 | $110.7M | $3.4M | ||
| Q3 24 | $132.3M | $23.6M | ||
| Q2 24 | $111.6M | $9.5M |
| Q1 26 | 33.0% | 10.7% | ||
| Q4 25 | 30.0% | 9.3% | ||
| Q3 25 | 30.4% | 12.0% | ||
| Q2 25 | 31.6% | 12.1% | ||
| Q1 25 | 33.7% | 12.7% | ||
| Q4 24 | 31.7% | 10.8% | ||
| Q3 24 | 33.6% | 13.8% | ||
| Q2 24 | 30.8% | 12.5% |
| Q1 26 | 21.4% | 4.7% | ||
| Q4 25 | 17.3% | 1.9% | ||
| Q3 25 | 18.9% | 3.7% | ||
| Q2 25 | 20.5% | 3.0% | ||
| Q1 25 | 22.8% | 4.8% | ||
| Q4 24 | 20.3% | 1.5% | ||
| Q3 24 | 23.4% | 4.4% | ||
| Q2 24 | 20.7% | 3.4% |
| Q1 26 | 17.6% | 3.3% | ||
| Q4 25 | 12.8% | 0.9% | ||
| Q3 25 | 14.5% | 1.8% | ||
| Q2 25 | 15.9% | 1.9% | ||
| Q1 25 | 18.0% | 3.3% | ||
| Q4 24 | 16.9% | 0.6% | ||
| Q3 24 | 18.3% | 4.3% | ||
| Q2 24 | 15.7% | 1.7% |
| Q1 26 | $12.62 | $0.86 | ||
| Q4 25 | $8.67 | $0.22 | ||
| Q3 25 | $10.67 | $0.47 | ||
| Q2 25 | $11.84 | $0.50 | ||
| Q1 25 | $13.26 | $0.86 | ||
| Q4 24 | $11.57 | $0.14 | ||
| Q3 24 | $13.79 | $1.03 | ||
| Q2 24 | $11.63 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $73.2M | — |
| Total DebtLower is stronger | $939.6M | $328.4M |
| Stockholders' EquityBook value | $1.7B | $1.2B |
| Total Assets | $3.5B | $2.3B |
| Debt / EquityLower = less leverage | 0.54× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $73.2M | — | ||
| Q4 25 | $77.6M | $132.7M | ||
| Q3 25 | $102.5M | $118.5M | ||
| Q2 25 | $70.3M | $88.9M | ||
| Q1 25 | $118.3M | $107.5M | ||
| Q4 24 | $77.5M | $99.7M | ||
| Q3 24 | $80.3M | $147.3M | ||
| Q2 24 | $87.6M | $124.7M |
| Q1 26 | $939.6M | $328.4M | ||
| Q4 25 | $883.4M | $626.7M | ||
| Q3 25 | $783.1M | $655.5M | ||
| Q2 25 | $841.8M | $658.0M | ||
| Q1 25 | $990.6M | $659.3M | ||
| Q4 24 | $971.3M | $625.4M | ||
| Q3 24 | $1.1B | $688.5M | ||
| Q2 24 | $1.2B | $657.1M |
| Q1 26 | $1.7B | $1.2B | ||
| Q4 25 | $1.8B | $1.2B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B |
| Q1 26 | $3.5B | $2.3B | ||
| Q4 25 | $3.5B | $2.4B | ||
| Q3 25 | $3.2B | $2.4B | ||
| Q2 25 | $3.2B | $2.4B | ||
| Q1 25 | $3.2B | $2.4B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.2B | $2.4B | ||
| Q2 24 | $3.2B | $2.3B |
| Q1 26 | 0.54× | 0.28× | ||
| Q4 25 | 0.50× | 0.50× | ||
| Q3 25 | 0.46× | 0.53× | ||
| Q2 25 | 0.52× | 0.53× | ||
| Q1 25 | 0.65× | 0.55× | ||
| Q4 24 | 0.66× | 0.53× | ||
| Q3 24 | 0.80× | 0.56× | ||
| Q2 24 | 0.95× | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NEU
Segment breakdown not available.
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
